3M’s Dividend Is Growing Again. Can PFAS Derail It?
With personal-injury claims still unresolved and the Solventum stake swinging reported earnings, income investors need to look past the headline number today.
Top News
France’s Budget Has No Majority. The OAT Spread Keeps Score.
Saturday’s 550,000-person protest is the backdrop. Monday’s bonds are the verdict.
Varonis Got a 52% Premium. What That Tells You About Data Security Prices.
Thoma Bravo’s $6.3 billion all-cash bid for Varonis says something specific about where buyers think AI-era data security is undervalued.
NatWest Walks Away From the Bond Market at Its Most Expensive in 24 Years
The bank’s exit from US and European primary dealing raises a harder question: who fills the gap when government debt is this hard to sell?
Medicare Just Got More Complex for 2027 Enrollment
Fewer plan choices open Oct. 15, and Humana’s star surge is moving stocks.
Boots Is Worth $8.9 Billion. You Were Never Going to Own It.
The Weston family and Fairfax just claimed a storied UK retailer. The lesson is about who gets the best assets.
Insurance Giants Are Settling Claims in Seconds. Here Is What That Costs Adjusters.
Computer vision and agentic AI are compressing claim cycles, but the ROI story is messier than the headlines.
Ithaca Energy’s $860m Canada Bet: Growth Engine or Liability Trap?
The North Sea producer is buying into Newfoundland offshore oil. The math is compelling. The liabilities are not nothing.
Constellation Brands Reports Monday. Beer Is Stabilizing.
STZ at 9.6x forward earnings near its 52-week low. Does October 6 mark the bottom?
Accenture Is Down 33% in 2026. Today’s Numbers Tell Us Why.
Q4 results are out today. Federal stabilization and FY2027 guidance matter most.